• 1
    Lazarus A, Song S, Crow AR. Understanding platelet function through signal transduction. Transfus Med Rev 2003; 17: 4556.DOI: 10.1053/tmrv.2003.50002
  • 2
    Renaud S, De Lorgeril M. Wine, alcohol, and the French paradox for coronary heart disease. Lancet 1992; 339: 5235.DOI: 10.1016/0140-6736(92)90341-Y
  • 3
    Law M, Wald N. Why heart disease and mortality is low in France: the time lag explanation. BMJ 1999; 318: 147180.
  • 4
    Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998; 68: 25865.
  • 5
    Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, Katan MB. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998; 67: 25562.
  • 6
    Pearson DA, Paglieroni TG, Rein D, Wun T, Schramm DD, Wang JF, Holt RR, Gosselin R, Schmitz HH, Keen CL. The effects of flavonol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res 2002; 106: 1917.DOI: 10.1016/S0049-3848(02)00128-7
  • 7
    Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure–activity relations. Biochem Pharmacol 1984; 33: 152530.DOI: 10.1016/0006-2952(84)90423-4
  • 8
    Polette A, Lemaitre D, Lagarde M, Vericel E. N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins. Thromb Haemost 1996; 75: 9459.
  • 9
    Akyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem 1987; 262: 55925.
  • 10
    Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation 1997; 21: 34756.DOI: 10.1023/A:1027306118026
  • 11
    Lee HS, Ko HR, Ryu SY, Oh WK, Kim BY, Ahn SC, Mheen TI, Ahn JS. Inhibition of phospholipase C gamma 1 by the prenylated flavonoids from Sophora flavescens. Planta Med 1997; 63: 2668.
  • 12
    Chen S, Hwang J, Deng PSK. Inhibition of NAD (P) H:quinone acceptor oxidoreductase by flavones: a structure–activity study. Arch Biochem Biophys 1993; 302: 727.
  • 13
    Bucki R, Pastore JJ, Giraud F, Sulpice JC, Janmey PA. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis. J Thromb Haemost 2003; 1: 18208.
  • 14
    Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000; 72: 11505.
  • 15
    Freedman JE, Parker C III, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001; 103: 27928.
  • 16
    Hubbard GP, Stevens JM, Cicmil M, Sage T, Jordan PA, Williams CM, Lovegrove JA, Gibbins JM. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 2003; 1: 107988.DOI: 10.1046/j.1538-7836.2003.00212.x
  • 17
    Rivera J, Sanchez-Roig MJ, Rosillo MC, Moraleda JM, Vicente V. Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: detection by binding assays with epitope-defined monoclonal antibodies and physiological ligands. Vox Sang 1994; 67: 16671.
  • 18
    Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193204.
  • 19
    Holmsen H, Dangelmaier CA. Measurement of secretion of serotonin. Meth Enzymol 1989; 169: 20510.
  • 20
    Rivera J, Lozano ML, Corral J, Connor J, Gonzalez-Conejero R, Ferrer F, Currie L, Vicente V. Quality assessment of platelet concentrates supplemented with second-messenger effectors. Transfusion 1999; 39: 13543.DOI: 10.1046/j.1537-2995.1999.39299154726.x
  • 21
    Pace-Asciak CR, Reynaud D, Demin P, Aslam R, Sun A. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition. J Pharmacol Exp Ther 2002; 301: 61824.DOI: 10.1124/jpet.301.2.618
  • 22
    Son DJ, Cho MR, Kim SY, Park YH, Lee SH, Akiba S, Sato T, Yun YP. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 2531.DOI: 10.1016/j.plefa.2003.12.004
  • 23
    Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 120618.
  • 24
    Buccellati C, Ciceri P, Ballerio R, Casagrande C, Folco G, Nicosia S. Evaluation of the effects of anti-thromboxane agents in platelet–vessel wall interaction. Eur J Pharmacol 2002; 443: 13341.
  • 25
    Yamada N, Miyamoto M, Isogaya M, Suzuki M, Ikezawa S, Ohno M, Otake A, Umemura K. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets. J Thromb Haemost 2003; 1: 181319.DOI: 10.1046/j.1538-7836.2003.00257.x
  • 26
    Jacobson KA, Moro S, Manthey JA, West PL, Ji XD. Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol 2002; 505: 16371.
  • 27
    Mruk JS, Webster MWI, Heras M, Reid JM, Grill DE, Chesebro JH. Flavone-8-acetic acid (flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo. Circulation 2000; 101: 3248.
  • 28
    Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the French paradox. FASEB J 2002; 16: 195860.
  • 29
    Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits tromboxane A2-mediated human platelet response. Mol Pharmacol 1990; 39: 47580.
  • 30
    McNicol A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukot Essent Fatty Acids 1993; 48: 37984.DOI: 10.1016/0952-3278(93)90118-G
  • 31
    Yamakoshi J, Piskula MK, Izumi T, Tobe K, Saito M, Kataoka S, Obata A, Kikuchi M. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr 2000; 130: 188793.
  • 32
    Turek JW, Halmos T, Sullivan NL, Antonakis K, Le Breton GC. Mapping of a ligand-binding site for the human thromboxane A2 receptor protein. J Biol Chem 2002; 277: 167917.DOI: 10.1074/jbc.M105872200
  • 33
    Cho MJ, Liu J, Pestina TI, Steward SA, Thomas DW, Coffman TM, Wang D, Jackson CW, Gartner TK. The roles of αIIbβ3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation. Blood 2003; 101: 264651.
  • 34
    Murphy CT, Kellie S, Westwick J. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses. Eur J Biochem 1993; 216: 63951.
  • 35
    Agullo G, Gamet-payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997; 53: 164957.DOI: 10.1016/S0006-2952(97)82453-7
  • 36
    Polanowska-Grabowska R, Gibbins JM, Gear ARL. Platelet adhesion to collagen and collagen-related peptide under flow. Roles of the α2β1 integrin, GPVI, and Src tyrosine kinases. Arterioscler Thromb Vasc Biol 2003; 23: 193440.DOI: 10.1161/01.ATV.0000086937.46974.70